EPS (Diluted) for Insulet (PODD)
According to Insulet's latest reported financial statements, the company's current diluted EPS (TTM) is $3.50. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
PODD
Currently viewingEPS (Diluted)Switch metric
TTM (last 4 quarters)
$3.50
YoY change
-39.8%
5Y CAGR
+103.4%
Peak year (2024)
$5.78
Latest annual
$3.48
EPS (Diluted) history chart for Insulet (PODD) from 2002 to 2025
EPS (Diluted) history table for Insulet (PODD) from 2002 to 2025
| Fiscal year | Period ended | Reported | EPS (Diluted) | YoY |
|---|---|---|---|---|
| 2025 | $3.48 | -39.8% | ||
| 2024 | $5.78 | +96.6% | ||
| 2023 | $2.94 | +4368.1% | ||
| 2022 | $0.07 | -73.7% | ||
| 2021 | $0.25 | +150.0% | ||
| 2020 | $0.10 | -47.4% | ||
| 2019 | $0.19 | +251.9% | ||
| 2018 | $0.05 | -111.7% | ||
| 2017 | $-0.46 | -8.0% | ||
| 2016 | $-0.50 | -61.2% | ||
| 2015 | $-1.29 | +38.7% | ||
| 2014 | $-0.93 | +12.0% | ||
| 2013 | $-0.83 | -23.1% | ||
| 2012 | $-1.08 | -11.5% | ||
| 2011 | $-1.22 | -20.8% | ||
| 2010 | $-1.54 | -42.5% | ||
| 2009 | $-2.68 | -20.2% | ||
| 2008 | $-3.36 | +4.7% | ||
| 2007 | $-3.21 | -91.8% | ||
| 2006 | $-39.19 | -44.8% | ||
| 2005 | $-70.95 | +48.9% | ||
| 2004 | $-47.64 | +8.6% | ||
| 2003 | $-43.88 | +3.7% | ||
| 2002 | $-42.30 | — |
EPS (Diluted) values are taken from Insulet's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Insulet (PODD) reported diluted EPS of $3.48 – plunged 39.8% year-over-year.
Across 2020–2025 (5 years), Insulet diluted EPS produced a CAGR of +103.4% – with the latest reading among the more recent periods of the dataset.
Between 2024 and 2025, Insulet diluted EPS plunged 39.8%, falling from $5.78 to $3.48.
The dataset's maximum diluted EPS sits at $5.78 (2024); the minimum reading of $-70.95 dates to 2005.
Insulet (PODD) sits 8th of 8 Healthcare peers we track on this metric, against a peer median of $13.16.
Insulet EPS (Diluted) by Year
Insulet EPS (Diluted) 2025: $3.48
Insulet diluted EPS in 2025 was $3.48, plunged 39.8% below 2024.
Insulet EPS (Diluted) 2024: $5.78
Insulet diluted EPS in 2024 was $5.78, surged 96.6% from 2023. This figure represents the highest annual value in the available history.
Insulet EPS (Diluted) 2023: $2.94
Insulet diluted EPS in 2023 was $2.94, surged 4368.1% from 2022.
Insulet EPS (Diluted) 2022: $0.07
Insulet diluted EPS in 2022 was $0.07, plunged 73.7% below 2021.
Insulet EPS (Diluted) 2021: $0.25
Insulet diluted EPS in 2021 was $0.25.
See more financial history for Insulet (PODD).
Sector peers — EPS (Diluted)
Companies in the same sector as Insulet, ranked by their latest diluted EPS.
| Company | EPS (Diluted) | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $23.03 | Healthcare |
| Eli Lilly and Company (LLY) | $22.95 | Healthcare |
| Amgen Inc. (AMGN) | $14.23 | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $13.23 | Healthcare |
| AstraZeneca PLC (AZN) | $13.08 | Healthcare |
| Johnson & Johnson (JNJ) | $11.03 | Healthcare |
| Merck & Co., Inc. (MRK) | $7.28 | Healthcare |
| AbbVie Inc. (ABBV) | $2.37 | Healthcare |
Frequently asked questions
What is Insulet's diluted EPS?
- Latest reported diluted EPS for Insulet (PODD) is $3.50 (period ending December 31, 2025).
How has Insulet diluted EPS changed year-over-year?
- Insulet (PODD) diluted EPS changed -39.8% year-over-year on the latest annual filing.
What is the long-term growth rate of Insulet diluted EPS?
- Insulet (PODD) diluted EPS compound annual growth rate is +103.4% over the most recent 5 years available.
When did Insulet diluted EPS hit its highest annual value?
- Insulet diluted EPS reached its highest annual value of $5.78 in 2024.
What was Insulet diluted EPS in 2024?
- Insulet (PODD) diluted EPS in 2024 was $5.78.
What was Insulet diluted EPS in 2025?
- Insulet (PODD) diluted EPS in 2025 was $3.48.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
PODD Overview
Company profile, financial tools, and key metrics
PODD Revenue Counter
Earns $85.88 every second. See per minute, hour, and day.
PODD Earnings Counter
Earns $7.84 per second net profit. See per minute, hour, and day.
PODD Economic Scale
Exceeds St. Lucia's GDP. Compare with world economies.
PODD What If Invested
What if you had invested $1,000? See historical returns from any date.
PODD How It Makes Money
Discover visual breakdown of $2.71B in revenue — where it comes from and where it goes.
PODD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
PODD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
PODD Daily Price Character
Explosive · 51.5% historical win rate (green days). Streaks & record days.
PODD Buybacks
0.30% TTM buyback yield. Shareholder yield & SBC comparison.